Kintegral Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Hold
10,244
0.06% 201
2026
Q1
$643K Sell
10,244
-454
-4% -$31.6K 0.06% 199
2025
Q4
$710K Sell
10,698
-293
-3% -$18.9K 0.06% 201
2025
Q3
$740K Sell
10,991
-49
-0.4% -$3.88K 0.06% 198
2025
Q2
$964K Sell
11,040
-17
-0.2% -$1.33K 0.09% 178
2025
Q1
$755K Sell
11,057
-37
-0.3% -$3.02K 0.08% 194
2024
Q4
$863K Sell
11,094
-517
-4% -$38.3K 0.08% 187
2024
Q3
$778K Sell
11,611
-152
-1% -$12.5K 0.07% 202
2024
Q2
$1.33M Buy
+11,763
New +$1.49M 0.13% 157

Other funds holding DXCM

Kintegral Advisory's DXCM Position: Q2 2026 in Review

Kintegral Advisory held its DexCom (DXCM) position steady in Q2 2026 at 10,244 shares worth $690K. The position accounts for 0.06% of the portfolio, ranked #201.

Kintegral Advisory first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.33M in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kintegral Advisory held 10,244 shares of DexCom worth $690K as of Q2 2026.
  • Kintegral Advisory left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.06% of Kintegral Advisory's portfolio in Q2 2026, its #201 holding.
  • Kintegral Advisory first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Kintegral Advisory's DexCom position peaked at $1.33M in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.